Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-2570 in moderate-to-severe plaque psoriasis (phase 3, placebo- and active-controlled)
CTR20254653Phase 3Active
- Sponsor
- InventisBio
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of D-2570 in plaque psoriasis, sponsored by InventisBio. Started Jan 2026; status: active.
02
Drugs
D-2570
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20254653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254653.